Suppr超能文献

甲状腺乳头状癌和滤泡状癌的同步侧方淋巴结转移:病例报告及文献复习

Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature.

作者信息

Stenman Adam, Kjellman Magnus, Zedenius Jan, Juhlin C Christofer

机构信息

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Thyroid Res. 2022 Feb 4;15(1):1. doi: 10.1186/s13044-022-00120-w.

Abstract

BACKGROUND

Follicular thyroid carcinomas (FTCs) rarely metastasize to regional lymph nodes, and descriptions of synchronous lateral lymph node metastases of FTC and papillary thyroid carcinoma (PTC) are lacking.

CASE PRESENTATION

We describe a 43-year-old female with a preoperative cytology indicating a right-sided PTC with lateral lymph node metastases. She underwent a total thyroidectomy and central and lateral lymph node dissection, and histopathology confirmed a multifocal tall cell variant PTC together with a 12 mm minimally invasive FTC in the ipsilateral lobe. While the central compartment demonstrated metastatic PTC, the lateral compartment contained PTC metastases alongside a 15 mm large follicular-patterned mass in a separate lymph node. As the cells lacked PTC associated nuclear changes, the possibility of a lateral lymph node metastasis of FTC was considered, with the possibility of ectopic thyroid tissue as a differential diagnosis. By utilizing next-generation sequencing, a Q61R NRAS mutation was pinpointed, thus proving the tissue as tumorous. The patient underwent radioiodine treatment and is currently monitored following a negative whole-body scan.

CONCLUSIONS

This is probably the first case report of a patient with co-existing lateral lymph node PTC and FTC metastases. Consulting previous publications, there is currently a gap of knowledge in terms of how patients with regional FTC metastases should be followed-up and treated, especially when co-occurring with spread high-risk PTC subtypes. Moreover, what guides a seemingly indolent FTC to spread via the lymphatic system remains to be defined from a molecular standpoint.

摘要

背景

滤泡性甲状腺癌(FTC)很少转移至区域淋巴结,且缺乏关于FTC与乳头状甲状腺癌(PTC)同步发生侧方淋巴结转移的描述。

病例介绍

我们描述了一名43岁女性,术前细胞学检查提示右侧PTC伴侧方淋巴结转移。她接受了全甲状腺切除术及中央区和侧方淋巴结清扫术,组织病理学证实为多灶性高细胞变异型PTC,同侧叶还有一个12毫米的微小浸润性FTC。中央区显示有转移性PTC,而侧方区除一个单独淋巴结中有一个15毫米大的滤泡样肿块外,还含有PTC转移灶。由于细胞缺乏与PTC相关的核变化,考虑为FTC侧方淋巴结转移的可能性,鉴别诊断为异位甲状腺组织。通过下一代测序,确定了一个Q61R NRAS突变,从而证明该组织为肿瘤性。患者接受了放射性碘治疗,目前全身扫描阴性,正在接受监测。

结论

这可能是首例同时存在侧方淋巴结PTC和FTC转移的患者的病例报告。查阅既往文献,目前在区域FTC转移患者应如何随访和治疗方面存在知识空白,尤其是当与高风险PTC亚型扩散同时发生时。此外,从分子角度来看,是什么因素导致看似惰性的FTC通过淋巴系统扩散仍有待确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5422/8815265/98370db31a6d/13044_2022_120_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验